SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-16-000610
Filing Date
2016-01-28
Accepted
2016-01-28 14:48:26
Documents
48
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rgbp12312015form10q.htm 10-Q 327291
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9297
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 8244
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4715
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4628
  Complete submission text file 0001607062-16-000610.txt   1545330

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20151231.xml EX-101.INS 146843
7 XBRL SCHEMA FILE rgbp-20151231.xsd EX-101.SCH 22705
8 XBRL CALCULATION FILE rgbp-20151231_cal.xml EX-101.CAL 28646
9 XBRL DEFINITION FILE rgbp-20151231_def.xml EX-101.DEF 55656
10 XBRL LABEL FILE rgbp-20151231_lab.xml EX-101.LAB 130087
11 XBRL PRESENTATION FILE rgbp-20151231_pre.xml EX-101.PRE 117813
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 161368148
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences